These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10197410)

  • 41. The mouse as a model for evaluation of hypotriglyceridemic drugs effects of nicotinic acid, clofibrate and ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate on plasma lipoproteins.
    Gustafsson K; Kiessling H
    Z Versuchstierkd; 1982; 24(5-6):271-7. PubMed ID: 7170839
    [No Abstract]   [Full Text] [Related]  

  • 42. Hypolipidemic activity of Indan--1--acetic acids.
    Adak M; Gupta JK
    Nepal Med Coll J; 2006 Mar; 8(1):22-6. PubMed ID: 16827085
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A new multifunctional hydroxytyrosol-clofibrate with hypolipidemic, antioxidant, and hepatoprotective effects.
    Xie YD; Chen ZZ; Shao LH; Wang QT; Li N; Lu WF; Xu YH; Gao YQ; Guo LY; Liu HL; Li YP; Yang GD; Bian XL
    Bioorg Med Chem Lett; 2018 Oct; 28(18):3119-3122. PubMed ID: 30119959
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diurnal lipid and lipoprotein profiles with bezafibrate and clofibrate in healthy volunteers.
    Oster P; Schlierf G; Lang PD; Mordasini R; Vollmar J
    Pharmatherapeutica; 1985; 4(5):267-77. PubMed ID: 4070320
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
    Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
    Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [On the effect of etofylline clofibrate on serum lipids and lipoproteins in patients with hyperlipoproteinemia of various degrees (author's transl)].
    Schneider J; Mühlfellner G; Mühlfellner O; Hausmann L; Schubotz R
    Arzneimittelforschung; 1980; 30(11b):2059-62. PubMed ID: 7194060
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Newer hypolipidemic compounds.
    Kritchevsky D
    Adv Exp Med Biol; 1975; 63():135-50. PubMed ID: 1106139
    [No Abstract]   [Full Text] [Related]  

  • 48. Modulation of lipoprotein production in Hep G2 cells by fenofibrate and clofibrate.
    Hahn SE; Goldberg DM
    Biochem Pharmacol; 1992 Feb; 43(3):625-33. PubMed ID: 1311585
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and hypolipidemic activities of 5-thienyl-4-oxazoleacetic acid derivatives.
    Moriya T; Takabe S; Maeda S; Matsumoto K; Takashima K; Mori T; Takeyama S
    J Med Chem; 1986 Mar; 29(3):333-41. PubMed ID: 3950914
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of clofibrate on cholesterol and lipid metabolism in ethanol - treated mice.
    Rawat AK
    Res Commun Chem Pathol Pharmacol; 1975 Mar; 10(3):501-10. PubMed ID: 1135514
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypolipidemic activity of 4-pyrimidinecarboxylic acids in CF1 mice.
    Hall IH; Cocolas GH; Williams WL
    J Pharm Sci; 1984 Dec; 73(12):1819-20. PubMed ID: 6527265
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypolipidemic activity of phthalimide derivatives. 2. N-phenylphthalimide and derivatives.
    Chapman JM; Voorstad PJ; Cocolas GH; Hall IH
    J Med Chem; 1983 Feb; 26(2):237-43. PubMed ID: 6131131
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of clofibrate, bile-sequestering agents and probucol on high-density lipoprotein levels.
    Glueck C
    Am J Cardiol; 1983 Aug; 52(4):28B-30B. PubMed ID: 6577781
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potential use of fenofibrate and other fibric acid derivatives in the clinic.
    Brown WV
    Am J Med; 1987 Nov; 83(5B):85-9. PubMed ID: 3688012
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genotoxicity of alpha-asarone analogues.
    Karwicka E; Marczewska J; Anuszewska E; Łozowicka B; Chilmonczyk Z
    Bioorg Med Chem; 2008 Jun; 16(11):6069-74. PubMed ID: 18487049
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypolipidemic activity in rodents of phenobarbital and related derivatives.
    Hall IH; Patrick MA; Maguire JH
    Arch Pharm (Weinheim); 1990 Sep; 323(9):579-86. PubMed ID: 2288480
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Comparative effects of clofibrate and tiadenol on the metabolism of cholesterol in rats and hamsters. I. Comparative action of clofibrate and tiadenol on hepatic and intestinal biosynthesis of cholesterol in hamsters and rats].
    Rousselet F; Fredj G; Clenet M
    Ann Pharm Fr; 1986; 44(4):269-76. PubMed ID: 3566092
    [No Abstract]   [Full Text] [Related]  

  • 59. Novel Phenoxazinones as potent agonist of PPAR-α: design, synthesis, molecular docking and in vivo studies.
    Ugwu DI; Okoro UC; Mishra NK; Okafor SN
    Lipids Health Dis; 2018 May; 17(1):120. PubMed ID: 29789011
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypolipidaemic activity of alpha-asarone in mice.
    Garduño L; Salazar M; Salazar S; Morelos ME; Labarrios F; Tamaríz J; Chamorro GA
    J Ethnopharmacol; 1997 Jan; 55(2):161-3. PubMed ID: 9032629
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.